SHINVA(SH:600587) Xin Lang Zheng Quan·2026-01-21 02:37Core Viewpoint - Xinhua Medical has experienced fluctuations in stock price and financial performance, with a notable decrease in revenue and net profit year-on-year, indicating potential challenges in the medical device sector [1][2]. Group 1: Stock Performance - On January 21, Xinhua Medical's stock rose by 2.05%, reaching 16.42 CNY per share, with a trading volume of 120 million CNY and a turnover rate of 1.22%, resulting in a total market capitalization of 9.961 billion CNY [1]. - Year-to-date, Xinhua Medical's stock price has increased by 14.03%, but it has seen a decline of 2.26% over the last five trading days, a rise of 12.16% over the last 20 days, and a modest increase of 1.67% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Xinhua Medical reported a revenue of 6.978 billion CNY, reflecting a year-on-year decrease of 6.00%, while the net profit attributable to shareholders was 434 million CNY, down 29.61% compared to the previous year [2]. - Since its A-share listing, Xinhua Medical has distributed a total of 9.63 billion CNY in dividends, with 607 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Xinhua Medical was 38,700, a decrease of 1.44% from the previous period, with an average of 15,610 circulating shares per shareholder, which is an increase of 1.46% [2]. - Among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF holds 13.7328 million shares, a decrease of 2.3604 million shares from the previous period, while Hong Kong Central Clearing Limited increased its holdings by 768,900 shares to 8.6891 million shares [3].